Japan Tissue Engineering Company., Ltd. is a medical biotechnology company. The Company develops regenerative medicine using tissue engineering technology. Japan Tissue Engineering also provides research support services.

Summary Of Financial Results For The Second Quarter 2026

[Summary] Financial Results For The Three Months

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Japan Tissue Engineering Co (7774 JP)

Summary Of Financial Results For The Second Quarter 2026

[Summary] Financial Results For The Three Months

[Delayed] Business Plan And Growth Potential

[Delayed] Non-Consolidated Financial Results For The Fiscal Year Ended March 31, 2025

[Delayed] Financial Report For The Fiscal Year Ending March 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)